Susquehanna International Group’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Susquehanna International Group’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,288	Closed	-$101K	–	14259
2022 Q3	$101K	Buy	+10,288	New	+$101K	﹤0.01%	11701

Other funds holding ORIAU

JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

GAM

Gritstone Asset Management Bethesda, Maryland $93.6M AUM 11.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's ORIAU Position: Q4 2022 in Review

Susquehanna International Group sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q4 2022, closing a stake of 10,288 shares — an estimated $101K sold.

Susquehanna International Group first reported a position in ORIAU in Q3 2022 and held it in 1 quarter. The position peaked at $101K in Q3 2022. 6 funds tracked by Wall St. Rank hold ORIAU as of Q4 2022.

Susquehanna International Group reported no remaining Orion Biotech Opportunities Corp. Units position as of Q4 2022 after selling out during the quarter.
Susquehanna International Group sold 10,288 Orion Biotech Opportunities Corp. Units shares in Q4 2022, an estimated $101K.
Susquehanna International Group first reported a position in Orion Biotech Opportunities Corp. Units in Q3 2022 and held it in 1 quarter.
Susquehanna International Group's Orion Biotech Opportunities Corp. Units position peaked at $101K in Q3 2022.
6 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.